Moreover, after treatment with chemotherapy medications, macrophages secreted IL-1β, which could activate downstream cancer signaling pathways and reduce the sensitivity of osteosarcoma to chemotherapeutic drugs. This evidence concerns the gene IL1B and osteosarcoma.